+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 48 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 6025422
The Medical Devices sector report, “Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Minimally Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimally Invasive Spinal Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimally Invasive Spinal Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimally Invasive Spinal Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Minimally Invasive Spinal Devices Overview
3 Products under Development
3.1 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
3.2 Minimally Invasive Spinal Devices - Pipeline Products by Segment
3.3 Minimally Invasive Spinal Devices - Pipeline Products by Territory
3.4 Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
3.5 Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
3.6 Minimally Invasive Spinal Devices - Ongoing Clinical Trials
4 Minimally Invasive Spinal Devices - Pipeline Products under Development by Companies
4.1 Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
4.2 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
5 Minimally Invasive Spinal Devices Companies and Product Overview
6 Minimally Invasive Spinal Devices- Recent Developments
6.1 Oct 08, 2024: SpineGuard Receives 510(K) Clearance For Cannulated PsiFGuard
6.2 Sep 30, 2024: SpineGuard Obtains FDA Clearance for Commercial Release of Its “PsiFGuard” New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
6.3 Jul 10, 2024: Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
6.4 Jul 04, 2024: SurGenTec Receives An Additional 510(K) Clearance For Ion Facet Screw System
6.5 May 30, 2024: Partnership With Key Opinion Leaders and Successful Trainings
6.6 Mar 12, 2024: Modified MAGEC X System for Early Onset Scoliosis Treatment Can Now be used in the UK
6.7 Feb 15, 2024: SurGenTec Receives Additional 510(K) Clearance For Ion Facet Screw System
6.8 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
6.9 Nov 13, 2023: Aurora Spine Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimally Invasive Spinal Devices - Pipeline Products by Segment
  • Minimally Invasive Spinal Devices - Pipeline Products by Territory
  • Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimally Invasive Spinal Devices - Ongoing Clinical Trials
  • Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimally Invasive Spinal Devices - Pipeline Products by Segment
  • Minimally Invasive Spinal Devices - Pipeline Products by Territory
  • Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimally Invasive Spinal Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bonovo Orthopedics Inc
  • CTL Amedica Corp
  • Discure Technologies Ltd
  • Implanet SA
  • Integra LifeSciences Holdings Corp
  • MicroPort Scientific Corp
  • OrthoPediatrics Corp
  • OxSonics Ltd
  • Safe SA
  • SeaSpine, Inc.
  • Spine Chronicle Japan Co Ltd
  • SpineGuard SA
  • SpinePoint LLC
  • Stryker Corp
  • SurGenTec LLC
  • The Chaim Sheba Medical Center
  • ZuriMED Technologies AG